BFEC
IMGN

Benjamin F. Edwards & Company’s Immunogen Inc IMGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-95
Closed – – 1790
2020
Q2 		$0 Buy
+95
New +$404 ﹤0.01% 1831
2019
Q4 		– Sell
-1,994
Closed -$5K – 1962
2019
Q3 		$5K Buy
+1,994
New +$5.29K ﹤0.01% 1594

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Benjamin F. Edwards & Company's IMGN Position: Q3 2020 in Review

Benjamin F. Edwards & Company sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 95 shares.

Benjamin F. Edwards & Company first reported a position in IMGN in Q3 2019 and held it in 2 quarters. The position peaked at $5K in Q3 2019. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • Benjamin F. Edwards & Company reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 95 Immunogen Inc shares in Q3 2020.
  • Benjamin F. Edwards & Company first reported a position in Immunogen Inc in Q3 2019 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Immunogen Inc position peaked at $5K in Q3 2019.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2020, filed 13 Nov 2020.